Why the study?
Is percutaneous closure of PFO and ASD with Occlutech Figulla devices safe and effective?
Population
143 patients undergoing transcatheter patent foramen ovale and secundum type atrial septal defect closure
Design
Cohort
Follow-up
mean 15.4 ± 9.6 months
Authors
Loading...
Supports safety of Occlutech Figulla devices for PFO/ASD closure; hypothesis-generating and should not yet change practice pending randomized data.
Is percutaneous closure of PFO and ASD with Occlutech Figulla devices safe and effective?
Percutaneous closure of PFO and secundum ASD using the Occlutech Figulla device is safe, feasible, and effective with a 100% implantation success rate and low complication rates.
Aytemir et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: